Eli Lilly and Co. on Wednesday reported a third-quarter profit of $970.3 million, falling short of Wall Street expectations, and revised its full-year profit guidance down, a move that sent its stock falling as much as 10% in premarket trading.... Read More
Senator Todd Young on Monday visited the 16 Tech innovation district to underscore the work of a young federal agency that wants to shake up the conventional model of funding biomedical research, which some say is too slow, by funding higher-profile projects.... Read More
Indianapolis-based biotech company GeniPhys has been awarded a $500,000 National Science Foundation grant to support the next steps toward commercialization of its collagen product used for soft tissue restoration.... Read More
Britain’s drug regulator approved Eli Lilly and Co.’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the Alzheimer’s treatment isn’t worth the cost to taxpayers.... Read More
Indianapolis-based SpectronRx announced Thursday that the radiopharmaceutical company has executed a binding agreement with a Belgian company to manufacture a promising cancer therapy for patients in Europe.... Read More
The U.S. Food and Drug Administration, after intense public pressure and a lawsuit, is reconsidering its declaration barely two weeks ago that a shortage of the appetite-suppressing drugs Mounjaro and Zepbound is over, a temporary about-face that...... Read More
The U.S. Food and Drug Administration has approved a monthly chewable tablet for dogs made by Elanco Animal Health that is designed to protect against six parasites. The product, called Credelio Quattro, is designed to protect against...... Read More
The CEO of BioCrossroads says Eli Lilly and Co.'s latest multibillion-dollar investment in the LEAP Lebanon Innovation District is tremendous for the state's life sciences ecosystem. Vince Wong told IIB that the benefits of Lilly's investment is twofold.... Read More
Eli Lilly and Co. said Wednesday it will invest an additional $4.5 billion at its manufacturing site at the LEAP Lebanon Innovation District in Boone County to create a new center for advanced manufacturing and drug development.... Read More
The life sciences company's shares began trading on Sept. 13, and co-founder and CEO Kent Hawryluk said on Inside INdiana Business with Gerry Dick that the move was like opening a door to resources they didn't have before.... Read More
Cook Group is suing an underwriter at Lloyd’s of London insurance group for breach of contract, saying it failed to honor a $10 million policy against claims by patients who said they were injured by medical devices produced by the company.... Read More
A California-based company that is developing an automatic, implantable insulin pump to control glucose levels for people with diabetes announced plans Monday to relocate to Westfield. PhysioLogic Devices Inc. will change its name to Portal Diabetes Inc.... Read More
A biotech company founded by a Purdue University chemistry professor has completed a $10.25 million Series A round of funding to further study its new influenza treatment that has shown rapid results.... Read More
The Indianapolis-based drugmaker filed a suit in federal court this month, challenging the U.S. Food and Drug Administration’s ruling that the company’s experimental obesity treatment does not contain more than 40 amino acids and is therefore not a protein.... Read More
The Indiana Biosciences Research Institute in Indianapolis is seeking applications for the second annual Quantum Leap Award. The award was established in 2023 with the goal of helping startups bring their innovations closer to commercialization.... Read More
North Carolina-based Labcorp is marking the completion of its expanded laboratory in Greenfield. While details of the company's investment were not disclosed, Labcorp said the facility will increase its global molecular bioanalytical capacity.... Read More
Greenfield-based Elanco said Thursday it is now taking orders for the product, called Zenrelia, and expects to start shipping it in the coming days. With the approval, Elanco will enter the estimated $1.7 billion global canine dermatology market.... Read More
Indiana University is teaming up with Indiana Biosciences Research Institute to create what they are calling a “joint center of excellence” to develop better personalized care for patients with diabetes, cancer, Alzheimer’s disease and pediatric rare disease. The two institutions said in a joint statement Wednesday the operation will be called The Joint Center of Excellence […]... Read More
Carmel-based MBX Biosciences Inc. saw it shares jump nearly 48% in its debut Friday on the Nasdaq. The five-year-old company is developing treatments for endocrine and metabolic disorders, such as hypoparathyroidism, post-bariatric hypoglycemia and obesity.... Read More
Indianapolis-based Eli Lilly and Co. on Thursday announced plans to spend $1.8 billion on two of its manufacturing sites in Ireland to boost production of medicines for Alzheimer’s disease, diabetes and obesity.... Read More
